Al-Modawat Specialized Medical Co.’s net profit fell by 67% to SAR 6.1 million in 2024 from SAR 18.6 million a year earlier.
Item | 2023 | 2024 | Change |
---|---|---|---|
Revenues | 74.31 | 75.49 | 1.6 % |
Gross Income | 40.63 | 31.01 | (23.7 %) |
Operating Income | 20.17 | 7.56 | (62.5 %) |
Net Income | 18.59 | 6.07 | (67.3 %) |
Average Shares | 19.00 | 23.75 | 25.0 % |
Earnings Per Share before unusual items (Riyals) | 0.98 | 0.26 | (73.9 %) |
EPS (Riyals) | 0.98 | 0.26 | (73.9 %) |
The company cited an increase in expenses related to upgrading the level of services and increasing the number of employees in preparation for the opening of new hospital and clinics.
Item | H2 2023 | H2 2024 | Change |
---|---|---|---|
Revenues | 37.13 | 38.20 | 2.9 % |
Gross Income | 19.23 | 13.68 | (28.8 %) |
Operating Income | 8.65 | 3.78 | (56.3 %) |
Net Income | 7.66 | 2.91 | (62.0 %) |
Average Shares | 19.00 | 23.75 | 25.0 % |
Earnings Per Share before unusual items (Riyals) | 0.40 | 0.12 | (69.6 %) |
EPS (Riyals) | 0.40 | 0.12 | (69.6 %) |
Item | H1 2024 | H2 2024 | Change |
---|---|---|---|
Revenues | 37.29 | 38.20 | 2.4 % |
Gross Income | 17.33 | 13.68 | (21.0 %) |
Operating Income | 3.79 | 3.78 | (0.3 %) |
Net Income | 3.16 | 2.91 | (7.9 %) |
Average Shares | 23.75 | 23.75 | - |
Earnings Per Share before unusual items (Riyals) | 0.13 | 0.12 | (7.9 %) |
EPS (Riyals) | 0.13 | 0.12 | (7.9 %) |
In H2 2024, the company’s net profit plunged 62% to SAR 2.9 million from SAR 7.6 million in H2 2023.
Similarly, Al-Modawat’s net earnings dropped by 7.9% from SAR 3.1 million in H1 2024.
Total shareholders’ equity, no minority interest, reached SAR 77.12 million as of Dec. 31, 2024, up from SAR 39.25 million a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: